Skip to main content

Article Filters

Clear Filters
Finish

Endotoxin Removal: From Bench to Process Scale

Published date: 08 December 2023

Back to Article Listing

Endotoxin or lipopolysaccharides (LPS) are highly toxic components of the cell wall of Gram-negative bacteria and are often present in significant amounts in bacterial cell expression systems such as E.coli.

A number of methods have been adopted for the removal of endotoxin based on adsorption, in particular ion exchange chromatography. Although downstream processing can significantly reduce endotoxin levels in the product, efficient and cost effective removal of residual endotoxin from biopharmaceutical preparations remains a challenge.

Astrea Bioseparations has developed a novel affinity chromatography adsorbent, EtoxiClear®, that is highly stable, robust and non-toxic, with a high affinity for bacterial endotoxin and low protein binding. EtoxiClear® is a cost effective and scalable technology designed for use in endotoxin removal applications including process development, sample/buffer preparation and product polishing steps used during cGMP manufacture of biological molecules.

This application note describes the use of EtoxiClear® to effectively remove endotoxin from a purified immunoglobulin protein solution at both bench scale and process scale; utilising Astrea Bioseparations' 100 mm diameter Evolve® Process Column.

Materials & Methods

A purified immunoglobulin solution (~12 mg/mL) was determined to have an endotoxin burden. As a result, both a 5 mL column and a 780 mL Evolve® Process Column were packed with EtoxiClear®, using the guidelines in Table 1, to demonstrate high endotoxin clearance at different process scales. Prior to application the columns were depyrogenated for 16 hours using 0.5 M sodium hydroxide (NaOH). The NaOH was removed using ~1 column volume (CV) of water for injection (WFI) followed by equilibration buffer. Then 2 CV of the purified immunoglobulin solution was loaded onto each column and the non-bound fraction collected.

 

Results

 

Conclusions

EtoxiClear® provides an immunoglobulin protein recovery of >96% for the 5 mL column (bench scale) and >99% recovery using the 780 mL column (100 mm diameter Evolve® Process Column). There is a 3 log removal of endotoxin to obtain <1 EU/mL in the non-bound fraction, with less than 0.1 EU/mg protein for the Evolve® Process Column.

As a result, EtoxiClear® shows high performance and scalability for endotoxin clearance with low protein binding at both bench and process scale. The Evolve® Process Column is well suited for EtoxiClear® endotoxin removal applications and with the option to purchase a dedicated refresh kit to replace all the wetted parts of the column (including the acrylic tube), this column range provides significant cost savings whilst eliminating the need to prove endotoxin clearance from previous product and cleaning validation.

Your basket

Your basket is empty. Continue shopping to add products to your basket.

Search our catalogue

Call Centre

Request Quote

Please enter the quantity of products you want a quote for

Please enter the date you need these products byPlease enter a date in the format DD/MM/YYYY

View Content

Please complete the form below to receive the requested content from Astrea Bioseparations. We will use the data you provide to send you relevant updates, special offers, and product-related information. See our Privacy Notice for details on how we use personal data.

If you have an account please log in to gain access to content. You can apply for an account here

Please enter a First Name

Please enter a valid First Name, the maximum length is 50 characters.

Please enter a Last Name

Please enter a valid Last Name, the maximum length is 50 characters.

Please enter a Company Name

Please enter a valid Company, the maximum length is 100 characters

Please enter a valid Email AddressPlease enter a valid Email AddressThe Email Address entered is already registered, please sign in with the Email Address or enter a different one

Please select a valid Telephone Number, the maximum length is 30 characters

Please enter a valid Telephone Number consisting only of the following characters and spaces ( ) + 0 1 2 3 4 5 6 7 8 9

Please select a State / Province / Territory

Please select a valid State / Province / Territory, the maximum length is 150 characters

Please select a Country

Data entered into form will be stored in your session (not in a cookie) to avoid having to re-enter in future form submissions.

Stock Up & Save on Chromatography Resins - Learn More

Endotoxin Removal: From Bench to Process Scale

Published date: 08 December 2023

Back to Article Listing

Endotoxin or lipopolysaccharides (LPS) are highly toxic components of the cell wall of Gram-negative bacteria and are often present in significant amounts in bacterial cell expression systems such as E.coli.

A number of methods have been adopted for the removal of endotoxin based on adsorption, in particular ion exchange chromatography. Although downstream processing can significantly reduce endotoxin levels in the product, efficient and cost effective removal of residual endotoxin from biopharmaceutical preparations remains a challenge.

Astrea Bioseparations has developed a novel affinity chromatography adsorbent, EtoxiClear®, that is highly stable, robust and non-toxic, with a high affinity for bacterial endotoxin and low protein binding. EtoxiClear® is a cost effective and scalable technology designed for use in endotoxin removal applications including process development, sample/buffer preparation and product polishing steps used during cGMP manufacture of biological molecules.

This application note describes the use of EtoxiClear® to effectively remove endotoxin from a purified immunoglobulin protein solution at both bench scale and process scale; utilising Astrea Bioseparations' 100 mm diameter Evolve® Process Column.

Materials & Methods

A purified immunoglobulin solution (~12 mg/mL) was determined to have an endotoxin burden. As a result, both a 5 mL column and a 780 mL Evolve® Process Column were packed with EtoxiClear®, using the guidelines in Table 1, to demonstrate high endotoxin clearance at different process scales. Prior to application the columns were depyrogenated for 16 hours using 0.5 M sodium hydroxide (NaOH). The NaOH was removed using ~1 column volume (CV) of water for injection (WFI) followed by equilibration buffer. Then 2 CV of the purified immunoglobulin solution was loaded onto each column and the non-bound fraction collected.

 

Results

 

Conclusions

EtoxiClear® provides an immunoglobulin protein recovery of >96% for the 5 mL column (bench scale) and >99% recovery using the 780 mL column (100 mm diameter Evolve® Process Column). There is a 3 log removal of endotoxin to obtain <1 EU/mL in the non-bound fraction, with less than 0.1 EU/mg protein for the Evolve® Process Column.

As a result, EtoxiClear® shows high performance and scalability for endotoxin clearance with low protein binding at both bench and process scale. The Evolve® Process Column is well suited for EtoxiClear® endotoxin removal applications and with the option to purchase a dedicated refresh kit to replace all the wetted parts of the column (including the acrylic tube), this column range provides significant cost savings whilst eliminating the need to prove endotoxin clearance from previous product and cleaning validation.

Call Centre Product Compare